Starpharma Holdings Ltd has released a press release.
SPL: Research & Option Agreement with Radiopharm Theranostics
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Starpharma Announces a Collaboration and License Agreement with Genentech
- Presentation to Accompany License Agreement with Genentech
- Starpharma Announces License Agreement with Genentech
- $3.7M R&D Tax Incentive Received
- FY25 Key Financial Results and Annual Report
Later from Starpharma
- Upfront payment of USD $5.5 million received from Genentech
- AGM Chair address and CEO presentation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Half Yearly Report and Accounts
- FDA confirms path to DEP HER2 first-in-human study
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma